Spadari R C, Lamas J L, De Moraes S
Department of Biophysics and Physiology, Faculty of Medical Sciences, Universidade Estadual de Campinas (UNICAMP), Cidade Universitária Zeferino Vaz, Campinas, SP, Brazil.
J Pharm Pharmacol. 1987 Aug;39(8):662-4. doi: 10.1111/j.2042-7158.1987.tb03451.x.
The effects of reserpine on the sensitivity of the isolated pacemaker from rat heart to the chronotropic effect of isoprenaline and noradrenaline were studied. A single large dose of reserpine (2.5 mg kg-1) administered to rats 24 h before killing induces supersensitivity of the isolated pacemaker to isoprenaline, leaving unaltered the responsiveness of the pacemaker to noradrenaline. Reserpine at the dose of 1.0 mg kg-1 did not alter the sensitivity of the pacemaker to the catecholamines. Only the larger dose of reserpine raised the corticosterone plasma level. It is possible that a corticosterone-mediated inhibition of the extraneuronal uptake process is responsible for the supersensitivity to isoprenaline. Large doses of reserpine should not be used in experiments aimed to study cardiac sensitivity to isoprenaline or extraneuronal uptake and metabolism of the catecholamine.
研究了利血平对大鼠心脏离体起搏器对异丙肾上腺素和去甲肾上腺素变时作用敏感性的影响。在处死大鼠前24小时给其单次大剂量利血平(2.5毫克/千克),可诱导离体起搏器对异丙肾上腺素超敏,而起搏器对去甲肾上腺素的反应性未改变。1.0毫克/千克剂量的利血平未改变起搏器对儿茶酚胺的敏感性。只有较大剂量的利血平会提高血浆皮质酮水平。皮质酮介导的对神经外摄取过程的抑制可能是对异丙肾上腺素超敏的原因。在旨在研究心脏对异丙肾上腺素的敏感性或儿茶酚胺的神经外摄取及代谢的实验中,不应使用大剂量利血平。